DAFTAR PUSTAKA

Aghazadeh-Habashi, A., Sattari, S., Pasutto, F., & Jamali, F. (2002). High
Performance Liquid Chromatographic Determination of Glucosamine in
Rat Plasma. J. Pharm. Pharmaceut. Sci. 5.

Aiache. (1993). Farmasetika 2: Biofarmasi, terjemahan Widji Soeratri, Airlangga

University Press.

Anggraeni, C. A. (2008). Pengaruh Bentuk Sediaan Krim, Gel, dan Salep

Terhadap Penetrasi Aminofilin sebagai Antiselulit secara In-vitro
Menggunakan Sel Difusi Franz, Skripsi S1, Departemen Farmasi, FMIPA
UI, Depok.

Anonim. (2004). Pedoman Uji Bioekivalensi, BPOM, Jakarta.

Asshauer, J. & Ullner, H. (1986). Quantitative analysis in HPLC. In H. Engelhardt

(Ed.). Practice of high performance liquid chromatography:
Applications, equipment, and quantitative analysis (pp. 66-110). Berlin:
Springer-Verlag.

Banakar, U. V., Osborne, D. W. (1991). Transdermal Drug Product Development,

Technomic Publishing, Switzerland.

Barry, B. W. (1983). Dermatological Formulation: Percutaneous Absorption.

Marcel Dekker, New York.

Barry, B. W. (1987). Mode of action of penetration enhancers in human skin. In

James M. Anderson & Sung Wan Kim (Ed). Advances in drug
delivery systems, 3 (pp. 85-97). Amsterdam: Elsevier.

Barry, B. W. (2001). Novel mechanisms and devices to enable successful

transdermal drug delivery. Eur. J. Pharm. Sci., 14, 101-114.

Brain, K. R., Walters, K. A., & Watkinson, A. C.. (2002). Methods for studying
percutaneous absorption. In Kenneth A. Walters (Ed.). Dermatological and
transdermal formulations. Marcel Dekker, New York.

Chamberlain, J. (1985). Analysis of Drugs in Biological Fluids, CRC Press

Inc. Boca Rator Florida, 1:201.

Chen, J. J., Lee, Y.C., Cheng, T.J., Hsiao, H.Y., & Chen, R.L. (2006).
Detemination of Glucosamine in Nutraceutical by Capillary
Electrophoresis Using in-Capillary OPA Labeling Techniques, J. Food
Drug Anal., 14(2), 203-207.

82 Universitas Indonesia
 83

Chien, Y. W. (1992). Novel Drug Delivery Systems, Marcel Dekker Inc., New
York.

Christina. (2010). Pengaruh Asam Oleat, Etanol, dan Urea terhadap Profil
Penetrasi Perkutan Glukosamin secara In Vitro Menggunakan Sel Difusi
Franz. Skripsi Sarjana Farmasi. FMIPA UI, Depok.

Covey, T. R., Crowther, J. B., Dewey, E. A., Henion, J. D. (1985). Thermospray

liquid chromatography/mass spectrometry determination of drugs and their
metabolites in biological fluids. Anal Chem. Feb;57(2):474-81 .

Covey, T.R., Lee, E.D., Henion, J.D. (1986). High-speed liquid

chromatography/tandem mass spectrometry for the determination of drugs
in biological samples. Anal Chem 58:2453-2460.

Daniels, R. (2004). Strategies for Skin Penetration Enhancement. Skin Care

Forum. [Link]

Dong, M. W. (2006). Modern HPLC for practicing scientists. New Jersey: John
Wiley & Sons.

Food and Drug Administration. (2001). Guidance for Industry: Bioanalytical

Method Validation.

Galzote, C., & Suero, M. (2008). Skin Assessment:Noninvasive Evaluation of

Skin in the Cosmetic Industry. In Kenneth A. Walters & Michael S.
Roberts. Dermatologic, Cosmeceutic, and Cosmetic Development
Therapeutic and Novel Approaches. New York: Informa Healthcare.

Gandjar, Ibnu Gholib & Abdul Rohman. (2007). Kimia Farmasi Analisis. Pustaka
Pelajar, Yogyakarta: 378-406.

Gouze1, J.. N., Stoddart, M. J., Gouze, E., Palmer, G. D. (2001). Interleukin-1β
down-regulates the expression of glucuronosyltransferase I, a key enzyme
priming glycosaminoglycan biosynthesis: Influence of glucosamine on
interleukin-1β-mediated effects in rat chondrocytes. Arthritis Rheum., 44,
2, 351-360.

Guy, R.H., Hadgraft, J. (1989). Selection of Drug Candidates for Transdermal

Drug Delivers in Transdermal Drug Delivery, Marcel Dekker, New York,
59-77.

Hanifah. (2007). Pengaruh Bentuk Sediaan Krim, Gel, dan Salep Terhadap
Penetrasi Kafein sebagai Antiselulit secara In-vitro Menggunakan Sel
Difusi Franz, Skripsi S1, FMIPA-UI, Depok.

Universitas Indonesia
 84

Hresko, R. C., Heimberg, H., Chi, M. M., Mueckler, M. (1998). Glucosamine-

induced insulin resistance in 3T3-L1 adipocytes is caused by depletion
of intracellular ATP. J. Biol. Chem, 273, 32, 20658-20668.

Hsieh, Y., & Korfmacher, W.A. (2006). Increasing Speed and Throughput When
Using HPLC-MS/MS Systems for Drug Metabolism and Pharmacokinetic
Screening, In Current Drug Metabolism Volume 7, Number 5, Pp. 479-
489.

Ibrahim, A., Jamali, F. (2010). Improved Sensitive High Performance Liquid

Chromatography Assay for Glucosamine in Human and Rat Biological .

Jager, M. W. de, Ponec, M., & Bouwstra, J. A.. (2007). The lipid organization in
stratum corneum and model systems based on ceramides. In Elka Touitou
& Brian W. Barry (Ed.). Enhancement in drug delivery. CRC Press,
United States of America.

Kenneth B. Tomer, M. Arthur Moseley, Leesa J. Deterding, Carol E. Parker.

(1994). Capillary liquid chromatography/mass spectrometry. Mass
Spectrometry Reviews, Vol 13, 1994, pp 431-457.

Kenneth A. Walters, Michael S. Roberts. (2008). Dermatologic, Cosmeceutic, and

Cosmetic Development Therapeutic and Novel Approaches. Informa
Healthcare USA, Inc. 52 Vanderbilt Avenue New York, NY 10017.

Kralovec, J. A. & Barrow, C. J.. (2008). Glucosamine production and

health benefit. In Colin J. Barrow & Fereidoon Shahidi
(Ed.). Marine nutraceuticals and functional foods (pp. 197-227). Boca
Raton: CRC Press.

Kydonieus AF, Wille JJ, Murphy GF. (2000). Fundamental concepts in

transdermal delivery of drugs; in Kydonieus AF, Wille JJ (eds):
Biochemical Modulation of Skin Reactions. Transdermals, Topicals,
Cosmetics. Boca Raton, CRC Press, 2000.

Lachman, L., Liebermann, H.A., and Kanig, J.L. (1989). Teori dan Praktek
Farmasi Industri. Judul asli: The Theory and Practice of Industrial
Pharmacy. (Penerjemah: Suyatmi, S.). Edisi Ketiga. Jakarta: UI Press.

Langley, L. L. (1980). Dynamic anatomy and physiology. United States of

America: McGraw-Hill.

Lee, C.W., Li, Z., Patel, K., Olobo, J.O., Lee, E.J.D., & Goh, L.B. (2009). The
Transdermal Profiles of Mediflex Glucosamine Cream in Mouse and Man.
Singapore: National University of Singapore.
Universitas Indonesia
 85

Lee, K. S., and D. G. Drescher. (1979). Derivatization of Cysteine and Cystine for
Fluorescence Amino Acid with the O-Phtaldialdehyde/2-Mercaptoethanol
Reagent, J. Biol. Chem., 14, 6248-6251.

Lockwood, B. (2007). Nutraceuticals 2nd ed. Pharmaceutical Press Cornwall: 19-

20.

Luciano, D. S. (1978). Human function and structure. United States of America:

McGraw-Hill.

Mitsui, T. (Ed.). (1997). New Cosmetic Science. Elsevier, Amsterdam: 19-21.

Oegema, T. R., Deloria, L. B., Sandy, J. D., Hart, D. (2002). Effect of oral
glucosamine on cartilage and meniscus in normal and chymopapain-
injected knees of young rabbits. Arthritis Rheum., 46, 9, 2495-2503.

Ouypornkochagorn, S., Feldmann, J. (2010). Dermal Uptake of Arsenic through

Human Skin Depends Strongly on Its Speciation, Environ. Sci. Technol.

Pavelká, K., Gatterová, J., Olejarová, M., Machacek, S., Giacovelli, G., Rovati, L.
C. (2002). Glucosamine sulfate use and delay of progression of knee
osteoarthritis: A 3-year, randomized, placebo-controlled, double-blind
study. Arch Intern Med, 162, 2113-2123.

Pena, Lorraine E. (1990). Gel dosage forms: Theory, formulation, and processing.
Dalam: Osborne, David W. & Anton H. Amann (eds.). 1990. Topical drug
delivery formulations. Marcel Dekker, New York: 381-388.

Potts, O. R., & Guy, R. H. (1997). Mechanisms of Transdermal Drug Delivery.

New York: Marcel Dekker.

Purwadi. (2007). Pengembangan metode kromatografi cair kinerja tinggi

untuk analisis glukosamin dalam plasma darah. Tesis Magister
Farmasi. Bandung: Sekolah Farmasi ITB.

Richy, F., Bruyere, O., Ethgen, O. (2003). Structural and symptomatic effect
efficacy of glucosamine and chondroitin in knee osteoarthritis: A
comprehensive meta-analysis. Arch Intern Med, 163, 1514-1522.

Roberts, M. S., Cross, S. E., & Pellett, M. A.. (2002). Skin transport. In Kenneth
A. Walters (Ed.). Dermatological and transdermal formulations.
Marcel Dekker, New York.

Universitas Indonesia
 86

Roberts, M. S. & Anissimov, Y. G.. (2005). Mathematical models in percutaneous

absorption. In Robert L. Bronaugh & Howard I. Maibach (Ed.).
Percutaneous absorption: Drugs-cosmetics-mechanisms-methodology (4
th ed) (pp. 1-5). Boca Raton: Taylor & Francis Group.

Rowe, R.C., Sheskey, P., & Owen, S.C. (Ed.). (2006). Handbook
of pharmaceutical excipients (5th ed.). London: Pharmaceutical Press.

Shao, Y., R. Alluri, M. Mummert, U. Kotter, and S. Lech. (2004). A Stability-

Indicating HPLC Methode for the Determination of Glucosamine in
Pharmaceutical Formulations. J. Pharmaceut. Biomed. Anal., 35(2004),
625-631.

Shargel, L., Wu-Pong, S. & Wu, A. B. C. (2004). Applied biopharmaceutics and

pharmakokinetics (5th ed).

Sinko, P. J. (2006). Martin's physical pharmacy and pharmaceutical

sciences: Physical chemical and biopharmaceutical principles in the
pharmaceutical sciences (5th ed.) United states of America: Lippincott
Williams & Wilkins.

Skouras, N.D. (2010). Human Skin - pH factor Biological functions, and types.
[Link]

Srivastava, P. (2006). Excipients for semisolid formulations. In Ashok Katdare &

Mahesh V. Chaubal (Ed.). Excipient development for pharmaceutical,
biotechnology, and drug delivery systems (pp. 204-208). New York:
Informa Healthcare.

Swarbrick, J & Boylan, J. (1995). Percutaneous Absorption. In Encyclopedia In

Encyclopedia of Pharmaceutical Technology, volume 6, Marcel Dekker
Inc., New York, 415-424.

Schleicher, E. D. & Weigert, C. (2000). Role of the hexosamine biosynthetic

pathway in diabetic nephropathy. Kidney Int. Suppl., 58, 77, 13-18.

Setnikar, I, & Rovatti, L.C. (2001). Absorption, Distribution, Metabolism, And

Excretion of Glucosamine Sulfate: A review. Arzneimittelforschung., 699-
725. Januari 5, 2010. [Link]

Shao, Y., Alluri, R., Mummert, M., Kotter, U., and Lech, S. (2004). A Stability-
Indicating HPLC Methode for the Determination of Glucosamine in
Pharmaceutical Formulations. J. Pharmaceut. Biomed. Anal., 35(2004),
625-631.

Universitas Indonesia
 87

Technical Resources International. (2002). Glucosamine Summary of data for

chemical selection. 12-16, 18.

Thakker, K. D. &. Chern, W. H. (2003). Development and validation of in vitro

release tests for semisolid dosage forms - Case study. Dissolution
Technologies, 10-15.

Thong, Zhai, & Maibach. (2007). Percutaneous Penetration Enhancers: An

Overview H.-Y. Thong H. Zhai H.I. Maibach.

Tojo, K. (1987). Design and calibration of in vitro permeation apparatus. In Yie

W. Chien (Ed.). Transdermal controlled systemic medications (pp.
127-158). New York: Marcel Dekker.

United states pharmacopoeia 30 - National formulary 25. (2006). USA: the

United States Pharmacopeial Convention.

Van Hal, D. A., Jeremiasse, E., Junginger, H. E., Spies, F., Bouwstra, J. A.
(1996). Structure of fully hydrated human stratum corneum: A freeze-
fracture electron microscopy study. J. Invest. Dermatol, 106, 1, 89- 95.
Januari 12, 2010. [Link]

Walters, K. A., & Roberts, Michael S. (2002). The structure and function of skin.
In Kenneth A. Walters (Ed.). Dermatological and transdermal
formulations. New York: Marcel Dekker.

Wester, R. C. & Maibach, H. I. (1990). In vitro testing of topical pharmaceutical

formulations. In David W. Osborne & Anton H. Amann (Ed.). Topical
drug delivery formulations (pp. 213-220). New York: Marcel Dekker.

Williams, A.C. & Barry, B. W. (2004). Penetration Enhancer, Advanced Drug

Delivery Review, no.56, 603-618.

Williams, A. C., & Barry, B. W. (2007). Chemical permeation enhancement.

In Elka Touitou & Brian W. Barry (Ed.). Enhancement in drug
delivery (pp 233-248). United States of America: CRC Press.

Zats, J. L. & Kushla, G. P. (1996). Gels. In H. A. Lieberman, M. M. Rieger & G.

S. Banker (Ed.). Pharmaceutical dosage forms: Disperse systems (pp. 495-
510). (2nd ed.) Vol. 2. New York: Marcel Dekker.

Zhang, J., Purdon, C.H., Smith, E.W., Maibach, H.I., and Surber, C. (2006).
Penetration Enhancement by Skin Hydration in Percutaneous Penetration
Enhancers 2nd edition Eric W. Smith Howard I. Maibach 2006

Universitas Indonesia